{"resourceType":"CodeSystem","id":"v2-0477","meta":{"profile":["http://hl7.org/fhir/StructureDefinition/shareablecodesystem"]},"language":"en","text":{"status":"additional","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">\n            <p>Controlled Substance Schedule</p>\n\n            <table class=\"grid\">\n              <tr>\n                <td>\n                  <b>Code</b>\n                </td>\n                <td>\n                  <b>Description</b>\n                </td>\n                <td>\n                  <b>Comment</b>\n                </td>\n                <td>\n                  <b>Version</b>\n                </td>\n              </tr>\n              <tr>\n                <td>I\n                  <a name=\"I\"> </a>\n                </td>\n                <td>Schedule I</td>\n                <td>Includes drugs that have a high potential for abuse, no currently accepted medical use in the United States and a lack of accepted safety for use under medical supervision.</td>\n                <td>added v2.5</td>\n              </tr>\n              <tr>\n                <td>II\n                  <a name=\"II\"> </a>\n                </td>\n                <td>Schedule II</td>\n                <td>Includes drugs having currently accepted medical use in the United States and a high abuse potential, with severe psychological or physical dependence liability.</td>\n                <td>added v2.5</td>\n              </tr>\n              <tr>\n                <td>III\n                  <a name=\"III\"> </a>\n                </td>\n                <td>Schedule III</td>\n                <td>Includes drugs having an abuse potential less than that of drugs listed in Schedules I and II. All CS III drugs have a currently accepted medical use in the United States.</td>\n                <td>added v2.5</td>\n              </tr>\n              <tr>\n                <td>IV\n                  <a name=\"IV\"> </a>\n                </td>\n                <td>Schedule IV</td>\n                <td>Includes drugs having a lesser potential for abuse than those listed in Schedule III. CS IV drugs have a currently accepted medical use in the United States.</td>\n                <td>added v2.5</td>\n              </tr>\n              <tr>\n                <td>V\n                  <a name=\"V\"> </a>\n                </td>\n                <td>Schedule V</td>\n                <td>Includes drugs having low abuse potential and limited physical or psychological dependence relative to those listed in IV and have an accepted medical use in the United States.</td>\n                <td>added v2.5</td>\n              </tr>\n              <tr>\n                <td>VI\n                  <a name=\"VI\"> </a>\n                </td>\n                <td>Schedule VI</td>\n                <td>State defined</td>\n                <td>added v2.5</td>\n              </tr>\n            </table>\n\n          </div>"},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status","valueCode":"external"},{"url":"http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm","valueInteger":0}],"url":"http://terminology.hl7.org/CodeSystem/v2-0477","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.18.304"}],"version":"2.9","name":"v2.0477","title":"v2 Controlled Substance Schedule","status":"active","experimental":false,"publisher":"HL7, Inc","contact":[{"telecom":[{"system":"url","value":"http://hl7.org"}]}],"description":"FHIR Value set/code system definition for HL7 v2 table 0477 ( Controlled Substance Schedule)","content":"complete","concept":[{"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/codesystem-concept-comments","valueString":"Includes drugs that have a high potential for abuse, no currently accepted medical use in the United States and a lack of accepted safety for use under medical supervision."}],"code":"I","display":"Schedule I"},{"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/codesystem-concept-comments","valueString":"Includes drugs having currently accepted medical use in the United States and a high abuse potential, with severe psychological or physical dependence liability."}],"code":"II","display":"Schedule II"},{"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/codesystem-concept-comments","valueString":"Includes drugs having an abuse potential less than that of drugs listed in Schedules I and II. All CS III drugs have a currently accepted medical use in the United States."}],"code":"III","display":"Schedule III"},{"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/codesystem-concept-comments","valueString":"Includes drugs having a lesser potential for abuse than those listed in Schedule III. CS IV drugs have a currently accepted medical use in the United States."}],"code":"IV","display":"Schedule IV"},{"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/codesystem-concept-comments","valueString":"Includes drugs having low abuse potential and limited physical or psychological dependence relative to those listed in IV and have an accepted medical use in the United States."}],"code":"V","display":"Schedule V"},{"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/codesystem-concept-comments","valueString":"State defined"}],"code":"VI","display":"Schedule VI"}]}